The trademark registration for AMYLIN was filed on March 4, 2011, and it was registered on August 15, 2011 under EUTM trademark no. 009786724.
The trademark is owned by ASTRAZENECA PHARMACEUTICALS LP and represented by ELZABURU, S.L.P. (EUIPO registered representative, ID no. 11849) as a holder of a trademark.
There were no oppositions raised during the publication period. The 90 day opposition period for this mark started on May 6, 2011.
Trademark registration is in force until March 4, 2021.
|Trademark Name||AMYLIN||Trademark No.||009786724|
|Filling Date||March 4, 2011||Registration Date||August 15, 2011|
|Reference||327256/JPC/sjc||Status Date||August 18, 2011|
|Owner||ASTRAZENECA PHARMACEUTICALS LP|
|Legal Status||Legal entity|
|Address||ASTRAZENECA PHARMACEUTICALS LP
1800 Concord Pike
Wilmington DE 19850
|Legal Status||Legal person|
Miguel Angel, 21
Pharmaceutical, Veterinary Products, Dietetic
Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, glucoregulatory disorders, diabetes, diabetic complications, hormonal diseases and disorders, overweight and obesity, cardiovascular diseases and disorders, gastrointestinal disorders, immunological disorders, inflammation and inflammatory diseases.
Disclaimer: The information provided on this page is considered public information by the European Union Intellectual Property Office and is provided for informational purposes only. It should not be construed as legal advice on any subject matter.